Sponsor
John James
Representative · R-MI
Representative · R-MI
The bill centralizes and coordinates federal diabetes prevention, research, and equity efforts—potentially improving outcomes for millions and reducing long‑term costs—while increasing near‑term federal/admin costs and risking funding shifts that could disrupt some existing programs and research funding.
People with diabetes and those at high risk would gain a coordinated national plan that strengthens prevention, screening, and early diagnosis efforts.
Patients and researchers could see faster progress toward new treatments because federal research and program activities would be coordinated, evaluated, and prioritized.
Medicare beneficiaries and families could face lower out-of-pocket and program costs if the Project's prioritized actions reduce the health and financial burden of diabetes over time.
Hospitals, state programs, and some existing diabetes initiatives could face reduced funding or elimination if the Project prioritizes or consolidates programs.
Taxpayers could bear higher federal administrative costs to implement and maintain the Project and produce annual reports through 2036.
Federal agencies and state partners would face additional data‑sharing and administrative burdens to compile required evaluations and reporting.
Based on analysis of 2 sections of legislative text.
Establishes a National Diabetes Project at HHS to create an integrated national plan, coordinate federal research/services, convene an advisory council, require data sharing, and report annually to Congress.
Official title: To establish the National Diabetes Project, and for other purposes.
Introduced June 4, 2026 by John James · Last progress June 4, 2026
Creates a National Diabetes Project inside the HHS Secretary’s office to build and keep an integrated national plan to prevent, halt, or reverse diabetes, coordinate federal diabetes research and services, improve early diagnosis and care coordination, and ensure inclusion of high‑risk racial and ethnic populations. The Secretary must oversee the Project, produce annual updated plans and reports to Congress, evaluate federal diabetes programs and budgets, and require data sharing from federal agencies. An Advisory Council with federal and 12 non‑federal members will meet publicly and advise the Secretary. The Project sunsets on December 31, 2036.